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111Aloe arborescens Miller, belonging to the Aloe genus (Liliaceae family), is one of the main varieties of Aloe used
worldwide. Although less characterized than the commonestAloe vera,Aloe arborescens is known to be richer in
beneﬁcial phytotherapeutic, anticancer, and radio-protective properties. It is commonly used as a pharmaceutical
ingredient for its effect in burn treatment and ability to increase skin wound healing properties. However, very
few studies have addressed the biological effects of Aloe at molecular level. The aim of the research is to provide
evidences for the antiproliferative properties of Aloe arborescens crude leaf extract using an integrated
proteomic and cellular biological approach. We analysed the composition of an Aloe arborescens leaf extract
by gas chromatography-mass spectrometry analysis. We found it rich in Aloe-emodin, a hydroxylanthraquinone
with known antitumoral activity and in several compounds with anti-oxidant properties. Accordingly, we show
that the Aloe extract has antiproliferative effects on several human transformed cell lines and exhibits
prodifferentiative effects on both primary and immortalized human keratinocyte. Proteomic analysis of whole
cell extracts revealed the presence of proteins with a strong antiproliferative and antimicrobial activity speciﬁcally
induced in human keratinocytes by Aloe treatment supporting its application as a therapeutical agent. Copyright
© 2013 John Wiley & Sons, Ltd.
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136INTRODUCTION
Plants and their extracts are appreciated for their speciﬁc
aroma, nutraceutical, and therapeutical properties, such
as antimicrobial, antiproliferative, anti-inﬂammatory,
immunostimulant, and antioxidative (Greathead, 2003).
Aloe arborescens Miller, belonging to the Aloe genus
(Liliaceae family), is one of the main varieties of Aloe
used worldwide. It is commercially grown in South
America (Brazil and Uruguay), South Africa and some
Asian countries. The concentrated active extract from
Aloe arborescens shares some therapeutical properties
with the well-known and studied Aloe vera and is
commonly used in medicinal applications to treat burn
wounds and help accelerating the healing process of the
skin. Recent studies have demonstrated that Aloe
arborescens has immunostimulating activity in animal
trials (Infascelli et al., 2010), and it was found to have
beneﬁcial phytotherapeutic and anticancer properties
(Lissoni et al., 2009). It is known that the anticancer
properties of Aloe arborescens depend not only on its
immuno-modulatory effect, but also on a direct inhibitionondence to: DrAlessandra Pollice, PhD.Dipartimento di Biologia
e Funzionale, Università di Napoli, ‘Federico II’, Via Cinzia,
ngelo, 80126 Napoli, Italy.
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P T R 4 9 3 9 No. of Pages: 10 ME:of cancer cell proliferation (Bedini et al., 2009). Immunos-
timulatory effects are due to acemannan, while antiproli-
ferative effects have been ascribed to anthracenic,
antraquinonic, and aloenin-like compounds (Lissoni
et al., 2009).Aloe arborescens is also known for its effective
burn treatment and ability to increase skin wound healing
properties. Furthermore, it has been shown to be useful in
reducing microbial growth and to kill a broad range of
viruses and fungi, thereby providing extraordinary support
for the gastrointestinal tract, mucous membranes, and
connective tissue (Falcetti A., personal communications).
To determine the therapeutic effects ofAloe arborescens,
a considerable number of clinical investigations have
been done; however, very few studies have addressed
the biological effects of Aloe at molecular level. The aim
of the present study is to analyse the cellular response to
treatment with Aloe arborescens crude leaf extract
through a biochemical and cellular approach in order to
support its application as a therapeutical agent.137
138
139
140
141MATERIALS AND METHODS
Preparation of the whole-leaf extract. Plants from
Italian farms (Marsala, Sicily) certiﬁed for organic
systems were cultivated in natural habitat and wereReceived 05 August 2012
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141harvested when they were older than 4 years. The leaves
were washed in tanks, laid in plastic bags, and succes-
sively washed at 25C and brushed in order to eliminate
external impurity. After air drying, the leaves were
submitted to a ‘cold method’ provided by HDR sas
(Caserta, Italy) which allows to extract the active
principles either from the inner part or from the cuticle.
Commercial preparation of Aloe extract was stabilized
by potassium sorbate and citric acid. Successively, the
extract was stored in stainless still containers which were
sealed to avoid air contact.
Cell culture and Aloe arborescens treatment. NHEK
primary cells, derived from neonatal foreskin, were
from Clonetics (San Diego, California).The HaCaT
(human spontaneously immortalized keratinocyte) and
MDA-MB231 (human breast adenocarcinoma) cell lines
weremaintained inDulbecco’s Modiﬁed Eagle’s Medium
(DMEM) supplemented with 10% fetal bovine serum
and 1% penicillin-streptomycin. The keratinocyte-
derived squamous carcinoma cell lines (SCC011 and
SCC012) were previously described (Lefort et al., 2007).
The A431 (human epidermoid carcinoma) cell line was
maintained in RPMI 1640 supplemented with 10% fetal
bovine serum and 1% penicillin-streptomycin. All cell
lines were cultured at 37C in humidiﬁed atmosphere of
5% CO2. Aliquots of Aloe arborescens fresh leaf extract
were centrifuged at 10000 rpm for 10 min and sterilized
using disposable Millex syringe ﬁlter units, pore size 0.22
mm (Millipore). Sterile extract was employed for the
treatment at 10, 20, and 50% v/v, as indicated, in cell
culture medium. Equal amounts of Aloe preservation
medium were added to control samples. Aloe-treated
and untreated cells were photographed and harvested
for Western-blot analysis as described below.
Cell growth analysis.HaCaTspontaneously immortalized
human keratinocytes, MDA-MB231 metastatic breast
adenocarcinoma, A431 human epidermoid carcinoma,
CaCo2 human epithelial colorectal adenocarcinoma cells,
SCC011, and SCC022 squamous cell carcinoma (SCC)
were plated in 35mm dishes, at a cell density of 1  105
cells/plate. Cells were cultured in complete growth
media supplemented or not with aliquots of fresh Aloe
arborescence extract (10% v/v) for 6, 24, 30, 48, and 54 h
collected, and counted in a Burker chamber. Cell extracts
from treated and untreated cells were prepared and
subjected to SDS-PAGE and immunoblot for gene-
expression analysis.
Flow cytometry analysis. After treatments, cells were
washed twice with phosphate-buffered saline (PBS)
and harvested with 0.05% trypsin in 0.15% Na2EDTA.
Cells were then centrifuged, washed in PBS, ﬁxed with
ice-cold 70% ethanol, and stored overnight at 4C.
Fixed cells were washed in PBS and then incubated with
propidium iodide (50 mg/ml) and RNAse A (10 mg/ml)
for 30 min at room temperature. Data acquisition was per-
formed using a CyAn ADP Flow Cytometer (Beckman
Coulter, Inc., Milano, Italy) and Summit Software.
Keratinocyte differentiation. Non tumorigenic HaCaT
cells were chosen because they retain the ability to differ-
entiate upon Ca2+ treatment thus representing an inter-
mediary between normal and cancerous keratinocytes.
HaCaT cells were grown to conﬂuence in completeCopyright © 2013 John Wiley & Sons, Ltd.growthmedium and switched into differentiationmedium
(serum-free DMEM) with 1.2 mM CaCl2 with or without
Aloe extract (10% v/v) for 6 days according to (Vivo et al.,
2009), with the exception that the medium was changed
every 48 h. Differentiated cells treated or not with Aloe
were photographed and harvested for SDS-PAGE and
immunoblot analysis as described below. NHEK cells
were propagated in serum-free keratinocyte growth
medium containing 0.05 mM calcium. NHEK cells with
70%–80% cell conﬂuency were switched to high-calcium
medium (1.2mM) to induce differentiation. Extracts from
Aloe-treated or untreated NHEK cells were then
subjected to SDS-PAGE and immunoblot analysis as
described below.
SDS-PAGE and immunoblot analysis. Aloe arborescens
treated and untreated cells were harvested in lysis buffer
(50 mM Tris–HCl pH 7.5, 5 mM EDTA, 150 mM NaCl,
1% NP-40, 1 mM phenylmethylsulfonyl ﬂuoride, 0.5%
sodium deoxycholate, and protease inhibitors). Cell
lysates were incubated on ice for 40 min, and the
extracts were centrifuged at 13200 rpm for 15 min to
remove cell debris. Protein concentrations were
determined by the Bio-Rad protein assay (Bio-Rad).
After the addition of 2 Laemmli buffer (SIGMA), the
samples were boiled at 100C for 5 min and resolved by
SDS-polyacrylamide gel electrophoresis. Proteins were
transferred to a polyvinylidene diﬂuoride membrane
(Millipore). The PVDF membrane was blocked in
5% w/v milk buffer (5% w/v non-fat dried milk, 50 mM
Tris, 200 mM NaCl, 0,2% Tween 20) and incubated with
primary antibodies diluted in 5%w/vmilk or bovine serum
albumine buffer for 2 h at room temperature or overnight
at 4C. Primary antibodies were anti-mouse p63-4A4
(Calbiochem), anti-mouse involucrin (Abcam antibody),
anti-mouse cytokeratin 1 (Santa-Cruz biotechnology), anti-
rabbit transglutaminase type 2 (Abcamantibody), anti-rabbit
pErks 42/44 (Cell signalling), anti-rabbit p21 (Santa-Cruz
biotechnology), anti-rabbit cyclin D1 (Cell Signalling),
anti-rabbit PARP-1 (Cell Signalling), and anti-goat b-actin
(Santa-Cruz biotechnology). Data were visualized by
enhanced chemiluminescence method (GE-Healthcare)
using HRP-conjugated secondary antibodies (Santa-Cruz
biotechnology) incubated for 1 h at room temperature
and analysed by Quantity One Wsoftware of ChemiDoc
TMXRS system (Bio-Rad).
Cell ﬂuorescent staining. SCC011 and SCC022 cells were
seeded on sterile coverslips and treated or not with Aloe
arborescens extract (10% v/v) for 48 h. After the
treatment, three washes with PBS were performed,
and cells were ﬁxed with 4% paraformaldehyde at RT
for 15 min. Then, cells were incubated with Wheat
Germ Agglutinin (WGA) membrane ﬂuorescent stain
(1:200) for 1 h at 37C. After three washes with PBS,
cells were permeabilized with 0.5% Triton-X100
(Sigma-Aldrich, Selze/Germany) at room temperature
for 5 min. Following permeabilization, cells were
incubated with DAPI (1:10000) for 3 min at RT. After
three washes with 0.05% PBS-Tween, slides were
mounted and analysed.
Metabolite analysis. Aliquots of commercial preparation
of aloe extract were submitted to liquid–liquid extraction
procedure by using equal amount of chloroform (1:1 v/v).
The extraction step was performed three times, and thePhytother. Res. (2013)
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141organic extracts were collected and dried. Analyte
mixtures were ﬁnally trimethylsilylated in 200 ml of N,
O-bis(trimethylsilyl) acetamide at 80C for 45 min. The
sample was dried down under nitrogen, dissolved in 50
ml of hexane, and centrifuged to remove the excess of
solid reagents. The hexane supernatant (1/50) was
used for the gas chromatography-mass spectrometry
(GC-MS) analysis.
GC-MS analysis. GC-MS analyses were performed on a
5390 MSD quadrupole mass spectrometer (Agilent
technologies) equipped with a gas chromatograph by
using a DB-5MS fused silica capillary column (30 m,
0.5 mm ID, 0.25 mm ft) from G&W. The injection
temperature was 250C. For lipid analyses, the oven
temperature was increased from 25C to 90C in 1 min
and held at 90C for 1 min before increasing to 140C
at 25C/min, to 200C at 5C/min and ﬁnally to 300C
at 10C/min. Electron Ionization mass spectra were
recorded by continuous quadrupole scanning at 70eV
ionization energy. Each species was interpreted on the
basis of electron impact spectra (NIST library and
Analyst Software).
Two-dimensional electrophoresis (2DE). The ﬁrst dimen-
sional electrophoresis (isoelectric focusing, IEF) was
carried out on non-linear wide-range immobilized pH
gradients (pH 4–7; 7 cm long IPG strips; GE Healthcare,
Uppsala, Sweden) and achieved using the Ettan IPGphor
system (GEHealthcare,Uppsala, Sweden). 200 mg of pro-
tein extracts was precipitated with methanol/chloroform
according to (Wessel and Flugge, 1984) and solubilized
in 125 ml of rehydratation buffer and 0.2% (v/v) carrier
ampholyte for 12 h, at 50 mA, at 20C. The strips were
then focused according to the following electrical
conditions at 20C: 500 V for 30 min, 1000 V for 30 min,
5000 V for 10h, until a total of 15000 Vt was reached.
After focusing, analytical and preparative IPG strips were
equilibrated for 15 min in 6 M urea, 30% (V/V) glycerol,
2% (w/V) SDS, 0.05 M Tris–HCl, pH 6.8, 1% (w/V)
dithiothreitol (DTT), and subsequently for 15 min in the
same urea/SDS/Tris buffer solution but substituting the
1% (w/V) DTT with 2.5% (w/V) iodoacetamide. The
second dimension was carried out on 12.5% (w/w)
polyacrylamide gels (10 cm  8 cm  0.75 mm) at
25 mA/gel constant current and 10C until the dye front
reached the bottom of the gel, according to (Laemmli,
1970; Hochstrasser et al., 1988). MS-preparative gels were
stained overnight with colloidal Coomassie Brilliant Blue
and destained with MilliQ grade water.
Image analysis.Gels images were acquired with an Epson
expression 1680 PRO scanner. Computer-aided 2-D
image analysis was carried out using the ImageMasterTM
2D Platinum software. Relative spot volumes (%V)
(V= integration of OD over the spot area; %V=V single
spot/V total spot) were used for quantitative analysis in
order to decrease experimental errors.
In situ digestion. Trypsin, DTT, iodoacetamide, and
R-cyano-4-hydroxycinnamic acid were purchased from
Sigma. NH4HCO3 was from Fluka. Triﬂuoroacetic acid-
high-performance liquid chromatography (HPLC) grade
was from Carlo Erba. All other reagents and solvents
were of the highest purity available from Baker. Analysis
was performed on the Coomassie blue-stained spotsCopyright © 2013 John Wiley & Sons, Ltd.excised from the gels. The spots were excised from the
gel and destained by repetitive washes with 0.1 M
NH4HCO3, pH 7.5, and acetonitrile. Samples were
reduced by incubation with 50 ml of 10 mM DTT in 0.1
M NH4HCO3 buffer, pH 7.5 and carboxyamidomethy-
lated with 50 ml of 55 mM iodoacetamide in the same
buffer. Enzymatic digestion was carried out with trypsin
(12.5 ng/ml) in 10 mM ammonium bicarbonate buffer,
pH 7.8. Gel pieces were incubated at 4C for 2 h.
Trypsin solution was then removed, and a new aliquot
of the same solution was added; samples were incu-
bated for 16 h at 37C. A minimum reaction volume
was used as to obtain the complete rehydration of the
gel. Peptides were then extracted by washing the gel par-
ticles with 10 mM ammonium bicarbonate and 1% formic
acid in 50% acetonitrile at room temperature. The result-
ing peptide mixtures were ﬁltrated using 0.22 PDVF ﬁlter
from Millipore, following the recommended procedure.
NanoHPLC-chip MS/MS analysis. The peptide mixtures
were analysed using a CHIP MS 6520 QTOF equipped
with a capillary 1200 HPLC system and a chip cube
(Agilent Technologies, Palo Alto, Ca). After loading,
the peptide mixture (8 ml in 0.1% formic acid) was ﬁrst
concentrated and washed at 4 ml min-1 in 40 nl enrichment
column (Agilent Technologies chip), with 0.1% formic
acid in 2% acetonitrile as eluent. The sample was then
fractionated on a C18 reverse-phase capillary column
(75 mm  43 mm in the Agilent Technologies chip) at
ﬂow rate of 400 nl min-1 with a linear gradient of eluent
B (0.1% formic acid in 95% acetonitrile) in A (0.1%
formic acid in 2% acetonitrile) from 7 to 60% in 50 min.
Peptide analysis was performed using data-dependent
acquisition of one MS scan (mass range from 400 to
2000 m/z) followed by MS/MS scans of the three most
abundant ions in each MS scan. The acquired MS/MS
spectra were transformed in Mascot generic ﬁle format
and used for peptides identiﬁcation with a licensed
version of MASCOT 2.1, in a local database (Swiss Pro).
Protein identiﬁcation. Raw data from nano-LC–MS/MS
were analysed using Qualitative Analysis software, and
MSMS spectra were searched against non-redundant pro-
tein databases (NCBInr 20090924, 9760158 sequences)
and UniprotSwissprot (2011, 167910 sequences), with
the taxonomy restriction toHomo sapiens, using in-house
MASCOT 2.1 software (Matrix Science, Boston, USA).
The Mascot search parameters were: ‘trypsin’ as
enzyme allowing up to three missed cleavages,
carbamidomethyl on as ﬁxed modiﬁcation, oxidation
of M, pyroGlu N-term Q, as variable modiﬁcations,
20 ppmMSMS tolerance, and 0.6 Da peptide tolerance.
The score used to evaluate quality of matches for
MSMS data was higher than 32.
Phase-contrast microscopy. HaCaT and A431 cells were
grown and (HaCaT) induced to differentiate on glass
coverslips in six-well plates, washed with PBS and
ﬁxed with cold methanol for 10 min. Treated and not-
treated cells were photographed (40) with Olympus
BX51 microscope.
Bacterial strains and growth conditions. Bacterial strains
used in this study were Bacillus cereus (6A2) (Naclerio
et al., 1993), Staphylococcus aureus (ATCC 6538),Listeria
monocitogenes (ATCC 7644), Salmonella typhimuriumPhytother. Res. (2013)
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102(ATCC 14028), Shigella sonnei (ATCC25931),Escherichia
coli (DH5a), Bacillus subtilis (PY79) (Youngman et al.,
1984), Lactobacillus mucosae (SF1031), and Lactobacillus
gasseri (SF1109) (Fakhry et al., 2009). Lactobacilli cultures
were cultured inMRS broth (Difco) at 37C inmicroaero-
philic conditions, while for all other strains, LB medium
(8 g/l NaCl, 10 g/l tryptone, 5 g/l yeast extract) and aerobic
conditions at 37C were used. Aloe-containing liquid
media, obtained by adding 2 ml of an aqueous Aloe leaf
extract to 8 ml of LB orMRSmedia, were inoculated with
0.1ml of an overnight culture and growth at 37C followed
for 8-12 h by spectrophotometer (OD600) analysis.
Plate antibacterial assays. For each indicator strain
utilized, 100 ml aliquots of exponential growth cultures
was mixed with 10 ml of LB or MRS soft agar (0.7%).
Plates were then spotted with 10 ml of Aloe arborescens
extract, incubated at 37C and the inhibition halo
measured as previously reported (Baccigalupi et al.,
2005). The effects of Aloe arborescens extracts on
bacterial growth were also measured on LB and MRS
agar plates prepared by adding various dilutions of Aloe
extract (1:1, 1:5, 1:10) to the media and then spotting on
the solidiﬁed plates aliquots (10 ml) of each bacterial
culture in stationary growth phase.Aloe-containing plates
were then incubated 37C and checked for bacterial
growth after 24 and 48 h.F1
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111RESULTS AND DISCUSSION
GC-MS analysis
The composition of the Aloe arborescens preparation
was determined by GC-MS analyses following liquid–Table 1. List of species identiﬁed by GC-MS in the Aloe arborescens
percentage of total volume injected. Preservatives are indicated in bold
Peak No Retention time (min) Comp
1 4.28 Sorbic acid
2 5.00 Benzoic acid
3 5.16 Phosphoric acid
4 5.76 Succinic acid
5 6.17 Itaconic acid
6 7.54 Octanoic acid
7 8.68 Malic acid
8 9.19 4-hydroxycyclohexylcarboxy
9 10.08 Rythronic acid
10 10.58 a-hydroxycinnamic acid
11 12.01 Pimelic acid
12 13.17 Isocitric acid lactone
13 13.50 Cyclooctene-1,2-diol
14 13.71 Tricarballylic acid
15 14.21 para-Coumaric acid
16 14.72 Terephtalic acid
17 15.27 Citric
18 16.37 Ferulic acid
19 17.11 2,4,6-tri-tert-butylphenol
20 18.34 Palmitic acid
21 19.92 1H-Indole-2,3-dione-6-ethox
22 22.26 1,8-Dihydroxy-3-(hydroxyme
(Aloe-emodin)
Copyright © 2013 John Wiley & Sons, Ltd.liquid extraction of different analytes from the extract.
The extracted mixture of species was derivatized to
TMS derivatives and directly analysed by GC-MS by
monitoring the total ion current as a function of time.
Each species was univocally identiﬁed on the basis of the
electron impact fragmentation spectra. All the analyses
were performed as triplicates. The chromatograms of
organic phase extracted in chloroform essentially revealed
the presence of hesenoic (C6H12O2), sorbic (C6H8O2),
and benzoic acid (C6H8O7). In the aqueous phase, 22
predominant species were identiﬁed and are listed in
Table 1. Aloin, one of the main component of Aloe
species with known pharmacological activities, was
not detected, while a signiﬁcant amount of Aloe-
emodin, a hydroxylanthraquinone having speciﬁc
antineuroectodermal tumor activity (Pecere et al., 2000),
was present (14%).Aloe arborescens affects cancer cell proliferation
It is already known that Aloe arborescens has antiproli-
ferative and anticancer effects (Lissoni et al., 2009; Bedini
et al., 2009); however, the molecular mechanisms underly-
ing the cellular response to Aloe treatment remains to be
deﬁned. This prompted us to analyse the effect of anAloe
arborescens leaf extract on cell proliferation at cellular
and molecular level, by comparing the rate of cell prolif-
eration, the cell-cycle distribution, and the expression of
cell-cycle-related molecular markers in Aloe-treated and
untreated human cells. These analyses were performed
in A431 (epidermoid skin carcinoma), MDA-MB231
(metastatic breast cancer), CaCo-2 (epithelial colorectal
adenocarcinoma), and HaCaT spontaneously immorta-
lized keratinocytes. As shown in Fig. 1, we reproduciblycommercial preparation. The relative abundance is expressed as
.
ound Molecular formula % of total
C6H8O2 3.88
C7H6O2 10.95
H3PO4 9.27
C4H6O4 11.67
C5H6O4 0.27
C8H16O2 0.10
C4H6O5 0.06
lic acid C7H12O3 1.76
C16H40O5Si4 0.08
C9H10O3 0.11
C7H12O4 0.35
C6H6O6 0.39
C8H14O2 0.21
C6H8O6 0.96
C9H8O3 0.38
C8H6O4 0.08
acid C6H807 44.74
C10H10O4 0.15
C18H30O 0.24
C16H32O2 0.10
y C22H22N2O5 0.08
thyl)-9,10-anthracenedione C15H10O5 14.01
Phytother. Res. (2013)
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F2
Figure 1. (A) ProliferatingHaCaT, (B)MDA-MB231, (C) CaCo-2, (D) A431 cellswere incubated in complete cell culturemedium supplemented or
not with Aloe extract (1:10 v/v). Control and Aloe-treated cells were collected at 6, 24, 30, 48, and 54 h and counted in a Burker chamber. (E)
Proliferating CaCo-2, (F) MDA-231, (G) A431 cells were incubated in complete cell culture medium supplemented or notAloe extract (1:10 v/v).
Control andAloe-treated cells were harvested at indicated different times (h). Equal amount of cell lysateswas subjected to immunoblot analysis
with antibodies against cyclin D1 and p21WAF. Actin was used as a loading control.
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141found that Aloe extract reduces the cell proliferation rate
in all cell lines tested. At 54 h of exposure toAloe, a 30 to
40% reduction in the number of cells was observed in
MDA-MB231, CaCo2, and HaCaTcells, while A431 cells
stopped to proliferate and underwent a drastic massive
cell death (Fig. 1D). The cell-cycle distribution of control
and Aloe-treated cells by ﬂow cytometry shows that
HaCaT cells display only a slight increase (3%) in the
percentage of G2/M cells after 48 h of Aloe treatment
(Fig. 2), while the other cell lines tested display an
increase of cells in S and/or G2/M phase with a compensa-
tory decrease of G0/G1 phase population indicating that
cells were unable to resume the cell cycle at normal phase
transit rate. Moreover, except for HaCaT keratinocytes,
Aloe treatment also caused a signiﬁcant increase in sub-
G1 cell population.
Expression of the cell-cycle markers p21WAF and
Cyclin D1 was also investigated to explore Aloe effect at
the molecular level. Immunoblots with the appropriate
antibodies show thatAloe treatment signiﬁcantly induced
p21WAF in all tumor cells tested, while Cyclin D1 expres-
sion was inhibited in CaCo-2 and MDA-MB231 cells
(Fig. 1E and F). Cyclin D1 is a labile factor required at
high level for progression through theG1 phase of the cellCopyright © 2013 John Wiley & Sons, Ltd.cycle. Mitogenic pathways directly up-regulate the
expression of Cyclin D1; therefore, impaired induction
of Cyclin D1 with the concomitant increase of p21WAF
is perfectly in line with the ineffectiveness ofAloe-treated
cells to efﬁciently resume the cell cycle. Unexpectedly,
A431 cells seemed to be unable to regulate Cyclin D1
expression (Fig. 1G). We can speculate that the delay
or failure of Cyclin D1 induction with the concomitant
increase of p21WAF might be responsible, at least in
part, for the massive A431 cell detachment at 54 h of
Aloe treatment. Importantly, although we observed an
increase of sub-G1 cells upon Aloe treatment (Fig. 2),
we were unable to observe PARP-1 cleavage by
western blot analyses (see Supplementary Fig. 1a)
thereby indicating thatAloe treatment was not inducing
apoptosis. Annexin V assay conﬁrmed the result (see
Supplementary Fig.1b).Aloe arborescens induces keratinocyte differentiation
The concentrated leaf extract from Aloe arborescens
plants has been used for hundreds of years in medicinal
applications to help accelerating the healing process ofPhytother. Res. (2013)
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Figure 2. Representative data obtained from flow-cytometric analysis of cell cycle of HaCat, MDA-MB231, CaCo-2, and A-431cells incu-
bated with or without Aloe for 48 h.
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141the skin. Therefore, we decided to analyse the effect of
Aloe arborescens on differentiation of human keratino-
cytes. We decided to compare the behavior of HaCaT
cells (spontaneously immortalized human keratinocytes)
that retain the ability to differentiate uponCa2+ treatment
with that of human primary keratinocytes. Addition of
calcium to keratinocyte cultures is the most physiological
stimulus to elicit a rather complete differentiation
program, inducing not only biochemical markers but also
many of the structural changes occurring in vivo (Dotto,
1999). To check whether the differentiation proﬁle is
altered by Aloe treatment, HaCaT cells were induced to
terminally differentiate by adding 1.2 mM calcium in a
serum-free medium, supplemented or not with Aloe
extract. After 6 days of culture,Aloe-treated cells became
shrunked and pluristratiﬁed (Fig. 3A). To provide
molecular evidence that differentiation was anticipated by
Aloe treatment, we performed immunoblot analyses on
extracts derived from treated and untreated cells. In parti-
cular, we observed that Involucrin and Transglutaminase,
two well-characterized differentiation markers (Paramio
and Jorcano, 1997), were expressed at higher levels in
Aloe-treated cells. Conversely, ΔNp63a that is associatedCopyright © 2013 John Wiley & Sons, Ltd.with the proliferative potential of epithelial cells and
disappears in terminally differentiated keratinocytes
(Di Costanzo et al., 2009) was down-regulated earlier
upon Aloe treatment (Fig. 3B).
In human primary keratinocytes (NHEK), Aloe treat-
ment caused a dramatic increase of Involucrin gene
expression that was already evident after 1 day of
treatment. Similar to what we have observed in HaCaT
cells, ΔNp63a level decreased faster in Aloe-treated
keratinocytes compared with control cells (Fig. 3C).
We then looked more deeply into the effect of Aloe
treatment during the early phases of HaCaT cell
differentiation. To this purpose, HaCaT cells were
seeded at medium density (2.5105) in complete medium
supplemented or not with Aloe extract (1:10 v/v) and
collected before Aloe addition (t0) or after 6, 24, 30, 48,
and 54 h after Aloe treatment (Fig. 3D). Equal amounts
of cell lysates were subjected to immunoblot analysis to
detect endogenous p21WAF and Cyclin D1. ΔNp63a
and Cytokeratin 1 (CK1) were also monitored as early
differentiation markers. As shown in Fig. 3D, we initially
observed an increase of Cyclin D1 protein levels both in
Aloe-treated and untreated keratinocytes. However,Phytother. Res. (2013)
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Figure 3. (A) Confluent HaCaT cells were induced to terminally differentiate by serum withdrawal and calcium addition (1,2 mM) in DMEM
cell culture media supplemented or not with Aloe extract (1:10 v/v). After 6 days of culture, treated and non-treated cells were fixed with
cold methanol and analysed by phase-contrast microscopy. (B) Differentiated HaCaT and (C) NHEK cells in presence or absence of Aloe
extract (1:10 v/v) were collected at different indicated times. Equal amount of cell lysates was subjected to immunoblot analysis with
antibodies against ΔNp63a, involucrin, and transglutaminase type II. Actin was used as a loading control. (D) Proliferating HaCaTcells were
incubated in DMEM or DMEM Aloe extract containing medium (1:10 v/v). Control and Aloe-treated cells were collected at 6, 24, 30, 48, and
54 h. Equal amount of cell lysates was subjected to immunoblot analysis with antibodies against ΔNp63a, cyclin D1, p21WAF, and Keratin
1, an early differentiation marker. Actin was used as a loading control. (E) Proliferating HaCaTcells were incubated in DMEM or DMEM Aloe
extract containing medium (20% or 50% v/v). Control and Aloe-treated cells were collected at 24 h. Equal amount of cell lysates were
subjected to immunoblot analysis with antibodies against cyclin D1, p21WAF, Keratin 1, an early differentiation marker, and PARP-1. Actin
was used as a loading control.
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141according to what observed in tumor cells, Cyclin D1
tended to be down-regulated faster in Aloe-treated
HaCaT cells while the p21WAF protein was up-regulated
only in Aloe-treated cells. At 54 h of Aloe treatment, the
remarkable decrease of Cyclin D1 along with sustained
expression of p21WAF indicates that keratinocytes were
anticipating cell-cycle withdrawal. p21WAF-depleted
keratinocytes exhibit an increased proliferative potential
and a drastic down-modulation of keratinocyte differ-
entiation markers (Di Cunto et al., 1998) pointing to
an essential involvement of p21WAF in the control of
keratinocyte terminal differentiation. In line with these
observations, compared to control cells, Aloe-treated
keratinocytes exhibited higher levels of p21WAF
and CK1, in agreement with the induction of aCopyright © 2013 John Wiley & Sons, Ltd.differentiation program. However, the persistence of
ΔNp63a protein expression indicates that both treated
and untreated keratinocytes were not fully differentiated
(Fig. 3D).
Cyclin D1 protein is known to increase under
mitogenic signals, through activation of the ERK’s
pathway. Remarkably, immunoblot analysis of lysates
from proliferating HaCaT keratinocytes treated for
24 h with increasing amounts ofAloe arborescens extract
(20% or 50% v/v) show that the reduction of Cyclin D1
and phosphorylated ERKs, as well as the induction of
p21WAF and CK1, was dose dependent. Moreover,
the signal corresponding to the cleavage of PARP1
was not enhanced, thus indicating that cells were not
undergoing apoptosis (Fig. 3E).Phytother. Res. (2013)
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treatment on squamous carcinoma cell lines (SCC011
and SCC022). SCC is an uncontrolled growth of
abnormal cells arising in the squamous layer, which
composes most of the skin’s upper layers. SCC cells
retain high levels of ΔNp63a that is absolutely required
for the survival of early stages of the squamous carci-
noma. We ﬁrst determined the rate of cell proliferation
in control and Aloe-treated SCC011 and SCC022 cells.
As shown in Fig. 4A and B, in Aloe containing medium,
both SCC011 and SCC022 cells stop growing. The cell-
cycle proﬁle of Aloe-treated SCC022 cells reveals a
dramatic increase in percentage of sub-G1 cells at the
expenses of G1 and G2/M cells (Fig. 4C). In SCC011,
the increase of subG1 cells was less dramatic although
the S phase arrest was evident (Fig. 4D). Growth arrest
was associated with a characteristic enlarged and
ﬂattened cell morphology as shown by ﬂuorescence
microscopy in SCC011 cells (Fig. 4E). Interestingly,
compared to SCC022, SCC011 cells display a stronger
activation of the Akt survival marker (data not shown)
suggesting that Akt may, indeed, counteract Aloe-
induced cell death. Western blot analysis of control and
Aloe-treated SCC011 shows a dramatic decrease of
ΔNp63a and a concomitant increase of p21WAF andFigure 4. (A) Proliferating SCC022 and (B) SCC011 cells were incubate
extract (1:10 v/v). Control and Aloe-treated cells were collected at 6, 2
Representative data obtained from flow-cytometric analysis of cell cycle
48 h. (E) Representative images of SCC011 cells fluorescently stained
amount of cell lysates was subjected to immunoblot analysis with indica
Copyright © 2013 John Wiley & Sons, Ltd.CK1 polymers (Fig. 4F). Importantly, since it has been
shown that SCC011 and SCC022 proliferation is strictly
dependent on ΔNp63a (Rocco et al., 2006), the dramatic
reduction ofΔNp63a induced byAloe in these tumor cells
may account for the cell death observedAntibacterial tests
Inner leaf extract from Aloe vera was shown to inhibit
growth of Streptococcus and Shigella species in vitro
(Arunkumar and Muthuselvam, 2009). Aloe-emodin
has been proposed to have direct antimicrobial activity.
To assess whether theAloe aqueous extract had antibac-
terial effects, two different plate antibacterial assays
were performed with a panel of nine bacterial strains.
As a ﬁrst assay, LB or MRS plates were disseminated
with each of the bacterial strain and spotted with the
aliquots of Aloe extract. As a second assay, LB or
MRS solid media containing various amounts of Aloe
extract were spotted with aliquots of bacterial cells
previously grown in liquid media. With both assays, no
inhibition of bacterial growth was observed for any of
the nine bacterial strains analysed (data not shown).d in complete cell culture medium supplemented or not with Aloe
4, 30, 48, and 54 h and counted in a Burker chamber. (C) and (D)
of SCC022 and SCC011 cells incubated with or without Aloe for
with WGA (labeling membrane glycoproteins) or DAPI. (F) Equal
ted antibodies. Actin was used as a loading control.
Phytother. Res. (2013)
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Table 2. List of proteins differentially represented in Aloe-treated or control HaCaT cells identiﬁed by mass spectrometry.
Aloe-treated
Spot MW Score Protein Swissprot code Peptides Sequence coverage
1 72402 186 78 kDa glucose-regulated protein P11021 8 20%
2 50095 325 Tubulin beta chain P07437 11 34%
3 11391 37 Dermcidin P81605 3 30%
4 29843 60 Prohibitin P35232 6 25%
5 22826 175 Heat shock protein beta-1 P04792 4 33%
6 22436 53 UMP-CMP kinase P30085 4 42%
7 23569 47 Glutathione S-transferase P P09211 6 42%
8 17292 60 Stathmin P16949 2 18%
Control
Spot MW Score Protein Swissprot Code Peptides Sequence coverage
9 62255 83 Keratin, type I cytoskeletal 9 P35527 5 10%
10 71082 224 Heat shock cognate 71 kDa protein P11142 13 23%
11 73920 49 Stress-70 protein, mitochondrial P38646 7 12%
12 70294 68 Heat shock 70 kDa protein 1A/1B P08107 4 8%
13 61187 492 60 kDa heat shock protein, mitochondrial P10809 24 50%
14 42052 156 Actin, cytoplasmic 1 P60709 9 34%
15 32726 267 Nucleophosmin P06748 10 26%
16 27871 189 14-3-3 protein sigma P31947 9 37%
17 16827 101 Calmodulin P62158 2 29%
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141Proteomic analysis
Although Aloe arborescens extract has been largely used
for its immunostimulating and anticancer properties, little
is known of its impact at the proteome level. We thus
decided to look at cell proteome changes of HaCaT
keratinocytes induced byAloe treatment. Protein extracts
from untreated (Control) or Aloe-treated (Sample)
HaCaT cells were fractionated by 2D-GE and stained
with colloidal Blue Coomassie. The gels were run in tripli-
cate and compared using the ImageMaster 2D Platinum
6.0 software. A few initial reference points (landmarks)
were afﬁxed for gels alignment in the ﬁrst step of the
images analysis. The spots were detected on the gels and
the software ‘matched’ the gels and the corresponding
spots. The spots representing the same protein in
different gels were paired. Pairs were automatically
determined using ImageMaster powerful gel matching
algorithm. The different 2DE images were compared by
synchronized 3-D spots view. Among the spots corre-
sponding to Aloe-sensitive proteins clearly detected in
repeated trials, 17 were selected for proteomic analysis.
The image analysis enabled the identiﬁcation of eight
spots that were present either in higher amount or
exclusively in theAloe-treated sample, thereby indicating
that they were induced by Aloe treatment. In the control
sample, instead, nine spots that were undetectable or
whose signal decreased after Aloe treatment were
detected. These spots were selected for mass spectral
identiﬁcation by the merging of images analyses. Proteins
excised from the gel were reduced, alkylated, and, in situ,
digested with trypsin. The resulting peptide mixtures
were analysed by nanoLC/MS/MS experiments. The
peptide mixtures were fractionated by nanoHPLC and
sequenced by MS/MS, generating sequence information
on individual peptides. MSMS spectra were used to
search for a non-redundant sequence using the in-house
MASCOT software, thus taking advantage of the
speciﬁcity of trypsin and of the taxonomic category ofCopyright © 2013 John Wiley & Sons, Ltd.the samples. The number of measured masses that
matched within the given mass accuracy was recorded,
and the proteins that had the highest number of peptide
matches were examined leading to the identiﬁcation of
the protein components. As further selection criteria,
only the proteins, identiﬁed by MASCOT search with at
least two peptides and found exclusively in the replicates,
were selected. The list of proteins identiﬁed by this
approach is illustrated in Table 2.
Among the identiﬁed proteins, a signal corresponding
to Tubulin showed an increment in the treated sample as
well as that of a powerful antimicrobial peptide known
as Dermcidin (DCD). This observation was particularly
intriguing as we failed to detect a direct antimicrobial
activity of Aloe arborescens against several bacterial
strains (see above). DCD is constitutively expressed in
eccrine sweat glands and is part of the constitutive
innate defence of human skin and stimulates keratino-
cytes to produce cytokines and chemokines (Niyonsaba
et al., 2009). So far, no DCD expression was found,
neither at RNA nor at protein level, in primary
keratinocytes, ﬁbroblasts, and melanocytes both in
normal conditions, or in cells stimulated by LPS, TNFa,
or TPA. Although the Aloe ability to stimulate DCD
production by keratinocytes needs further investigations,
our observation provides a novel insight for the Aloe
implication in microbicidal ability and skin immunity.
Aloe treatment also induced the expression of molecules
involved in several aspects of keratinocyte proliferation
and differentiation such as GRP78, Prohibitin, and
Stathmin. Prohibitin is a potential tumor suppressor pro-
tein that exhibits growth suppressor ability by repressing
E2F-mediated gene transcription (Joshi et al., 2003).
Stathmin is a microtubule-destabilizing protein and, in
association with Tubulin and HSP70, was reported to be
functionally relevant in the control of numerous
regulatory pathways that require a reorganization of the
entire cytoskeleton. GRP78 (also known as HSRPA5)
was found to be increased in the suprabasal layers ofPhytother. Res. (2013)
142
143
144
Q17
Q18
Q19
Q20
Q21
Q22
10 B. DI LUCCIA ET AL.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89normal epidermis and can work as a molecular chaperone
in cooperation with other Heat Shock Proteins being
part of the unfolded protein response activated in differ-
entiating epidermal keratinocytes (Sugiura et al., 2009). In
Aloe-treated HaCaT cells, heat shock proteins, essential
for the survival of malignant cells, were under-represented.
However, heat-shock proteins also occur under non-
stressful conditions, simply ‘monitoring’ the cell’s
recycling or folding. Further experiments are needed to
clarify this phenomenon.
Remarkably, Calmodulin and Keratin 1 signals were
detected only in the control sample and disappeared fol-
lowing the Aloe treatment. The remaining proteins exhib-
ited a sensitive decrement in the Aloe-treated sample.90
91
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96CONCLUSIONS
The results presented in this study indicate a clear
antiproliferative effect of an Aloe extract on severalCopyright © 2013 John Wiley & Sons, Ltd.tumor cells and a prodifferentiative effect both on
primary and immortalized human keratinocytes.
For a medicinal application perspective, our study
supports the use of Aloe arborescens extract for topic
treatment of hyperproliferative skin diseases or skin
SCC. In vivo animal experimentation will be necessary
to further conﬁrm the proposed health beneﬁt of
the extract.Acknowledgements
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